BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30516998)

  • 1. Development of 2-(2-(3-(4-([
    Mori W; Yamasaki T; Fujinaga M; Ogawa M; Zhang Y; Hatori A; Xie L; Kumata K; Wakizaka H; Kurihara Y; Ohkubo T; Nengaki N; Zhang MR
    J Med Chem; 2019 Jan; 62(2):688-698. PubMed ID: 30516998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
    Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [
    Svedberg MM; Varnäs K; Varrone A; Mitsios N; Mulder J; Gulyás B; Beaumont V; Munoz-Sanjuan I; Zaleska MM; Schmidt CJ; Halldin C; Mrzljak L
    Brain Res; 2019 May; 1711():140-145. PubMed ID: 30664847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between [
    Mori W; Takei M; Furutsuka K; Fujinaga M; Kumata K; Muto M; Ohkubo T; Hashimoto H; Tamagnan G; Higuchi M; Kawamura K; Zhang MR
    Nucl Med Biol; 2017 Dec; 55():12-18. PubMed ID: 28972915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosynthesis and biological evaluation of the new PDE10A radioligand [
    Wagner S; Teodoro R; Deuther-Conrad W; Kranz M; Scheunemann M; Fischer S; Wenzel B; Egerland U; Hoefgen N; Steinbach J; Brust P
    J Labelled Comp Radiopharm; 2017 Jan; 60(1):36-48. PubMed ID: 27896836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates.
    Stepanov V; Takano A; Nakao R; Amini N; Miura S; Hasui T; Kimura H; Taniguchi T; Halldin C
    Nucl Med Biol; 2018 Feb; 57():12-19. PubMed ID: 29223715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
    Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
    Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
    Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D
    Fazio P; Schain M; Mrzljak L; Amini N; Nag S; Al-Tawil N; Fitzer-Attas CJ; Bronzova J; Landwehrmeyer B; Sampaio C; Halldin C; Varrone A
    Neuroimage; 2017 May; 152():330-339. PubMed ID: 28254508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects.
    Delnomdedieu M; Forsberg A; Ogden A; Fazio P; Yu CR; Stenkrona P; Duvvuri S; David W; Al-Tawil N; Vitolo OV; Amini N; Nag S; Halldin C; Varrone A
    Neuropharmacology; 2017 May; 117():171-181. PubMed ID: 28122201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMG 580: a novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer.
    Chen H; Lester-Zeiner D; Shi J; Miller S; Glaus C; Hu E; Chen N; Able J; Biorn C; Wong J; Ma J; Michelsen K; Hill Della Puppa G; Kazules T; Dou HH; Talreja S; Zhao X; Chen A; Rumfelt S; Kunz RK; Ye H; Thiel OR; Williamson T; Davis C; Porter A; Immke D; Allen JR; Treanor J
    J Pharmacol Exp Ther; 2015 Feb; 352(2):327-37. PubMed ID: 25502803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, in vivo occupancy, and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging.
    Andrés JI; De Angelis M; Alcázar J; Iturrino L; Langlois X; Dedeurwaerdere S; Lenaerts I; Vanhoof G; Celen S; Bormans G
    J Med Chem; 2011 Aug; 54(16):5820-35. PubMed ID: 21777010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
    Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
    J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain.
    Kehler J; Kilburn JP; Estrada S; Christensen SR; Wall A; Thibblin A; Lubberink M; Bundgaard C; Brennum LT; Steiniger-Brach B; Christoffersen CT; Timmermann S; Kreilgaard M; Antoni G; Bang-Andersen B; Nielsen J
    J Nucl Med; 2014 Sep; 55(9):1513-8. PubMed ID: 24994928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
    Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
    Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Fluorine-Containing Phosphodiesterase 10A (PDE10A) Inhibitors and the In Vivo Evaluation of F-18 Labeled PDE10A PET Tracers in Rodent and Nonhuman Primate.
    Li J; Zhang X; Jin H; Fan J; Flores H; Perlmutter JS; Tu Z
    J Med Chem; 2015 Nov; 58(21):8584-600. PubMed ID: 26430878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of [
    Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Nielsen J; Bundgaard C; Bang-Andersen B; Grimwood S; Halldin C; Farde L; Finnema SJ
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):308-320. PubMed ID: 27817159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
    Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
    Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
    Russell DS; Jennings DL; Barret O; Tamagnan GD; Carroll VM; Caillé F; Alagille D; Morley TJ; Papin C; Seibyl JP; Marek KL
    Neurology; 2016 Feb; 86(8):748-54. PubMed ID: 26802091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.